MEDP vs QGEN

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Jul 16, 2026

MEDP

57.5
AI Score
VS
QGEN Wins

QGEN

59.6
AI Score

Investment Advisor Scores

MEDP

58score
Recommendation
HOLD

QGEN

60score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric MEDP QGEN Winner
Revenue 2.53B 2.09B MEDP
Net Income 451.12M 424.88M MEDP
Net Margin 17.8% 20.3% QGEN
Operating Income 534.93M 465.85M MEDP
ROE 98.3% 11.2% MEDP
ROA 22.8% 6.8% MEDP
Total Assets 1.98B 6.28B QGEN
Cash 497.05M 839.00M QGEN
Current Ratio 0.74 3.90 QGEN
Free Cash Flow 681.87M 453.28M MEDP

Relative Price Performance (Last 90 Days)

MEDP 1M: +1.1% · 3M: +37.0% QGEN 1M: +6.0% · 3M: +22.1%

Current Technical Phase

MEDP

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (11.9% over 20 days), RSI 59

RSI (14): 58.9 · Price: $571.30

QGEN

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (7.7% over 20 days), RSI 56

RSI (14): 55.9 · Price: $41.48

Fundamentals Snapshot

Metric MEDP QGEN
Market Cap
Forward P/E 29.7 16.1
Trailing P/E 33.9 21.1
Revenue (TTM)
Revenue Growth 0.2% 0.0%
Gross Margin 0.7% 0.7%
Operating Margin 0.2% 0.2%
EPS 17.01 1.96
Dividend Yield 0.00%

Frequently Asked Questions

Based on our detailed analysis, QGEN is currently the stronger investment candidate, winning 4 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.